Dr. Anthony Magliocco, the Protean BioDiagnostics CEO will be presenting an update webinar on current and emerging biomarkers in immuno-oncology, on September 5th.
Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.
Some of the learning objectives of the webinar are : review of the immune system and cancer, current and Emerging predictive I-O biomarkers, and biomarker testing practicalities.